GENIALIS
Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkers and optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.
GENIALIS
Industry:
Artificial Intelligence Bioinformatics Biotechnology Data Integration Data Mining Data Visualization Health Care Life Science
Founded:
2011-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.genialis.com
Total Employee:
11+
Status:
Active
Contact:
(832) 356-4612
Email Addresses:
[email protected]
Total Funding:
2.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Font Awesome
Similar Organizations
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dilek Dayinlarli
Dilek Dayinlarli investment in Seed Round - Genialis
Redalpine
Redalpine investment in Seed Round - Genialis
First Star Ventures
First Star Ventures investment in Seed Round - Genialis
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Genialis
More informations about "Genialis"
Genialis, the RNA biomarker company
Genialis uses machine-learning to discover RNA biomarkers and position oncology drugs to advance translational research and cancer drug development. Reimagining biomarkers with RNA + AI: Precision Oncology for Every Patient โฆSee details»
Genialis - LinkedIn
Genialis develops and validates clinically actionable biomarkers informed by the worldโs most ethnographically diverse cancer data sets to better predict patient responses and guide โฆSee details»
Meet Our Team - Genialis
Genialis is the RNA biomarker company We are creating a world where healthcare delivers the best possible outcomes for patients, their families and communities. Genialis develops and โฆSee details»
Genialis Company Profile 2024: Valuation, Funding & Investors
Genialis is headquartered in MA. What is the size of Genialis? Genialis has 42 total employees. What industry is Genialis in? Genialisโs primary industry is Drug Discovery. Is Genialis a โฆSee details»
Compliance - Genialis
Genialis stands for excellence in compliance, setting the benchmark for data security and regulatory conformity in biotech. Committed to Ethics, Transparency, and Integrity At Genialis, โฆSee details»
Genialis - CRO Database - ICH GCP
Genialis is a data science and drug discovery company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at โฆSee details»
Genialis Company Profile - Office Locations, Competitors ... - Craft
Genialis has 5 employees at their 1 location and $2.43 m in total funding,. See insights on Genialis including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Genialis - Funding, Financials, Valuation & Investors - Crunchbase
Genialis is funded by 8 investors. redalpine and P5 Health Ventures are the most recent investors. Genialis has a post-money valuation in the range of $10M to $50M as of Mar 29, 2023, โฆSee details»
Genialis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Genialis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Genialis has 5 board members and โฆSee details»
Genialis, Inc. - Scientist.com
Genialis is a computational precision medicine company focused on oncology. We are the RNA biomarker company. We build algorithms for precision medicine in cancer. Get started If your โฆSee details»
Genialis Raises $13M to Build Clinical Biomarkers ... - Markets Insider
Mar 29, 2023 Genialis is attending AACR 2023 from April 14-19, 2023, in Orlando, Fla., where it is co-presenting a poster with OncXerna Therapeutics and Regeneron Pharmaceuticals.See details»
Targeted Cancer Treatments with Rafael Rosengarten from Genialis
Sep 4, 2023 Rafael predicts the future impact of Genialis and shares his goals for the company. Quotes: โ[Genialis applies] machine learning to try to help patients find the best drugs for their โฆSee details»
Genialis a Winner in Inc.โs 2023 Best in Business Awards in AI & Data
Dec 6, 2023 Genialis has been named as a winner in Inc.'s 2023 Best in Business list in the AI and Data category, a prestigious award honoring the businesses that have made the greatest โฆSee details»
Genialis Raises $13M to Build Clinical Biomarkers that Predict โฆ
Mar 29, 2023 Genialis is attending AACR 2023 from April 14-19, 2023, in Orlando, Fla., where it is co-presenting a poster with OncXerna Therapeutics and Regeneron Pharmaceuticals.See details»
Genialis Harnesses RNA-seq Platform to Advance Precision โฆ
Nov 9, 2020 Genialis remained an active member of the Alliance for Artificial Intelligence in Healthcare, most recently contributing to the organizationโs webinar series on the various โฆSee details»
Genialis Raises $13M to Build Clinical Biomarkers that Predict โฆ
Mar 29, 2023 Genialis also co-authored a paper in the Journal of Clinical Oncology describing OncXerna's navicixizumab ph1b trial, including retrospective analysis with the Xerna TME โฆSee details»
Rafael Rosengarten of Genialis On 5 Things We Must Do To
Oct 15, 2024 Genialis has recently begun discussions with a potential collaborator in India that is doing an ambitious job of bringing precision medicine tools, which have become rather โฆSee details»
Genialis Releases Improved Version of Expressions for Faster, More ...
Apr 20, 2022 Genialis is trusted by biopharma and big pharma alike, and together, we bring precision to medicine. Contacts. Andrea Vuturo [email protected] +1-415-689-8414 โฆSee details»
Talking Precision Medicine podcast E30: Genialis leadership
May 31, 2023 TPM E30 with the Genialis leadership team explores building an impactful company culture that puts people first in healthcare innovation. Welcome to Talking Precision โฆSee details»